What does APOTHEEK VAL-MEER do?

APOTHEEK VAL-MEER is a pharmacy in Riemst. Private Limited, started on 17 January 2019, 1 establishment.

What is the address of APOTHEEK VAL-MEER?

The registered office of APOTHEEK VAL-MEER is located at Rechtstraat 39, 3770 Riemst.

Is APOTHEEK VAL-MEER still active?

Yes. According to the CBE (30 October 2026) APOTHEEK VAL-MEER is active, legal situation “Normale toestand”, started on 17 January 2019.

Is APOTHEEK VAL-MEER registered on Peppol?

Yes, APOTHEEK VAL-MEER is registered on the Peppol network with ID 0208:0718796526.

What is the enterprise number of APOTHEEK VAL-MEER?

The enterprise number of APOTHEEK VAL-MEER is BE0718796526.

When was APOTHEEK VAL-MEER founded?

APOTHEEK VAL-MEER was founded on 17 January 2019.

Who are the directors of APOTHEEK VAL-MEER?

According to the 2025 annual accounts, the directors of APOTHEEK VAL-MEER are: DF Pharma Services BV, Pittevils Management BV.

Is APOTHEEK VAL-MEER a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 January 2019; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK VAL-MEER make in 2025?

APOTHEEK VAL-MEER posted a profit after taxes of € 130,123 in financial year 2025.

What is the revenue of APOTHEEK VAL-MEER?

As a small company, APOTHEEK VAL-MEER is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 192,313.

How many employees does APOTHEEK VAL-MEER have?

According to the 2025 annual accounts, APOTHEEK VAL-MEER has 0.6 full-time equivalents (FTE).

Does APOTHEEK VAL-MEER have a website?

Yes, APOTHEEK VAL-MEER has a website at apotheekval-meer.be.

APOTHEEK VAL-MEER (Private Limited) - Riemst

Dossier APOTHEEK VAL-MEER, printed on 30 October 2026 from databakkes.be/en/0718796526/apotheek-val-meer. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK VAL-MEER from Riemst, company number BE0718796526, closed financial year 2025 with a result of € 130,123 after tax. For that financial year APOTHEEK VAL-MEER recorded a gross margin of € 192,313 and equity of € 328,048. Compared with financial year 2024, the result moved from € 81,947 to € 130,123. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 12, 2026.

What it is worth Growing

€ 328,048

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 130,123

▲ 59% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 190,560

▲ 13% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 130,000 paid out

100 % of the profit went to the shareholders, mostly to DF PHARMA SERVICES (50 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

0.6

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 27,723

▲ 1% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,551

▼ 43% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 18 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 244,582

▼ 5% vs 2024

€ 13,470 is repaid this year. At this pace the long-term loan is gone in ≈ 18 years.

Owed to suppliers

€ 37,849

▼ 25% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 5,069

▲ 5% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 134,091 Gross margin 2022: € 134,091 First fiscal year in the series	€ 142,595 Gross margin 2023: € 142,595 ▲ 6% vs 2022 (€ 134,091) Favourable step	€ 143,178 Gross margin 2024: € 143,178 Unchanged (€ 142,595) Favourable step	€ 192,313 Gross margin 2025: € 192,313 ▲ 34% vs 2024 (€ 143,178) Favourable step	▲ 34%
Profit after taxes	€ 58,675 Profit after taxes 2022: € 58,675 First fiscal year in the series	€ 77,304 Profit after taxes 2023: € 77,304 ▲ 32% vs 2022 (€ 58,675) Favourable step	€ 81,947 Profit after taxes 2024: € 81,947 ▲ 6% vs 2023 (€ 77,304) Favourable step	€ 130,123 Profit after taxes 2025: € 130,123 ▲ 59% vs 2024 (€ 81,947) Favourable step	▲ 59%
Equity	€ 326,672 Equity 2022: € 326,672 First fiscal year in the series	€ 326,977 Equity 2023: € 326,977 Unchanged (€ 326,672) Favourable step	€ 327,924 Equity 2024: € 327,924 Unchanged (€ 326,977) Favourable step	€ 328,048 Equity 2025: € 328,048 Unchanged (€ 327,924) Favourable step
Total debts	€ 359,592 Total debts 2022: € 359,592 First fiscal year in the series	€ 379,054 Total debts 2023: € 379,054 ▲ 5% vs 2022 (€ 359,592) Unfavourable step	€ 409,765 Total debts 2024: € 409,765 ▲ 8% vs 2023 (€ 379,054) Unfavourable step	€ 435,498 Total debts 2025: € 435,498 ▲ 6% vs 2024 (€ 409,765) Unfavourable step	▲ 6%
Cash	€ 120,562 Cash 2022: € 120,562 First fiscal year in the series	€ 169,449 Cash 2023: € 169,449 ▲ 41% vs 2022 (€ 120,562) Favourable step	€ 168,997 Cash 2024: € 168,997 Unchanged (€ 169,449) Unfavourable step	€ 190,560 Cash 2025: € 190,560 ▲ 13% vs 2024 (€ 168,997) Favourable step	▲ 13%
Land & buildings	€ 297,778 Land & buildings 2022: € 297,778 First fiscal year in the series	€ 292,656 Land & buildings 2023: € 292,656 ▼ 2% vs 2022 (€ 297,778) Unchanged	€ 287,534 Land & buildings 2024: € 287,534 ▼ 2% vs 2023 (€ 292,656) Unchanged	€ 282,413 Land & buildings 2025: € 282,413 ▼ 2% vs 2024 (€ 287,534) Unchanged	▼ 2%
Retained profit	€ 314,272 Retained profit 2022: € 314,272 First fiscal year in the series	€ 314,577 Retained profit 2023: € 314,577 Unchanged (€ 314,272) Favourable step	€ 315,524 Retained profit 2024: € 315,524 Unchanged (€ 314,577) Favourable step	€ 315,648 Retained profit 2025: € 315,648 Unchanged (€ 315,524) Favourable step
Dividend	€ 57,000 Dividend 2022: € 57,000 First fiscal year in the series	€ 77,000 Dividend 2023: € 77,000 ▲ 35% vs 2022 (€ 57,000) Unchanged	€ 81,000 Dividend 2024: € 81,000 ▲ 5% vs 2023 (€ 77,000) Unchanged	€ 130,000 Dividend 2025: € 130,000 ▲ 60% vs 2024 (€ 81,000) Unchanged	▲ 60%
Bank debt	€ 277,207 Bank debt 2022: € 277,207 First fiscal year in the series	€ 264,248 Bank debt 2023: € 264,248 ▼ 5% vs 2022 (€ 277,207) Favourable step	€ 257,891 Bank debt 2024: € 257,891 ▼ 2% vs 2023 (€ 264,248) Favourable step	€ 244,582 Bank debt 2025: € 244,582 ▼ 5% vs 2024 (€ 257,891) Favourable step	▼ 5%
Balance sheet total	€ 686,264 Balance sheet total 2022: € 686,264 First fiscal year in the series	€ 706,031 Balance sheet total 2023: € 706,031 ▲ 3% vs 2022 (€ 686,264) Unchanged	€ 737,689 Balance sheet total 2024: € 737,689 ▲ 4% vs 2023 (€ 706,031) Unchanged	€ 763,545 Balance sheet total 2025: € 763,545 ▲ 4% vs 2024 (€ 737,689) Unchanged	▲ 4%
Employees (FTE)	-	0.6 Employees (FTE) 2023: 0.6 First fiscal year in the series	0.6 Employees (FTE) 2024: 0.6 Unchanged (0.6) Unchanged	0.6 Employees (FTE) 2025: 0.6 Unchanged (0.6) Unchanged

Key figures of APOTHEEK VAL-MEER, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK VAL-MEER?

What happened at APOTHEEK VAL-MEER in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 12, 2026 New annual accounts for financial year 2025: profit of € 130,123 (▲ 59% vs 2024). filed late Source: NBB ↗
Jan 17, 2019 New establishment in Riemst. KBO
Jan 17, 2019 Start of the company according to the CBE. KBO

In short

From € 58,675 profit in 2022 to € 130,123 profit in 2025.

Paid € 40,461 in corporate taxes since 2022.

Best year ever: 2025, with € 130,123 profit.

Paid out € 345,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

DF PHARMA SERVICES 50%

PITTEVILS MANAGEMENT 50%

The stake of DF PHARMA SERVICES, PITTEVILS MANAGEMENT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK VAL-MEER

Behind APOTHEEK VAL-MEER are DF Pharma Services BV and Pittevils Management BV. The shares are held by DF PHARMA SERVICES (50%) and PITTEVILS MANAGEMENT (50%).

Directors

According to the 2025 annual accounts

DF Pharma Services BV

Director · represented by Petra Foulon

Also active at: APOTHEEK FOULON

Pittevils Management BV

Director · represented by Lise Pittevils

Shareholders

DF PHARMA SERVICES

50%

PITTEVILS MANAGEMENT

50%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rechtstraat 39

3770 Riemst

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheekval-meer.be

Canonical: https://www.apotheekval-meer.be

Technologies

Advanced Custom FieldsLodashPWAReactWixlazysizes

Certifications & Partners

FEB/VBO

Hosting & Email

Email provider

one.com Mail

Hosting

WIX_COM, IL

Domain

apotheekval-meer.be

Registered

2021-12-13

Website info

HTTPS Ja

Languages NL

Features

Newsletter

Security

✓ HTTPS

✓ SPF

✓ DMARC

Network

✓ Load balancing

Details

Company number

0718.796.526

VAT number

BE 0718.796.526

Registered office

Rechtstraat 39, 3770 Riemst

Names & denominations

APOTHEEK VAL-MEER

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

17 January 2019

Peppol

Active · Active since 16 Nov 2025

Contact

apotheekval-meer.be +32 12 45 19 90

Activities · NACE

Detailhandel in farmaceutische producten

Vervaardiging van overige farmaceutische producten

Vervaardiging van geneesmiddelen

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK VAL-MEER

Financials

What happened to APOTHEEK VAL-MEER?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Website

Technologies

Certifications & Partners

Hosting & Email

Domain

Website info

Features

Security

Network

Details

Frequently asked questions